[Specifications for diagnosis and treatment of non-neonatal tetanus].


Journal

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
ISSN: 0253-9624
Titre abrégé: Zhonghua Yu Fang Yi Xue Za Zhi
Pays: China
ID NLM: 7904962

Informations de publication

Date de publication:
06 Dec 2019
Historique:
entrez: 5 12 2019
pubmed: 5 12 2019
medline: 25 12 2019
Statut: ppublish

Résumé

Tetanus consists of neonatal tetanus and non-neonatal tetanus. Although neonatal tetanus in China has been eliminated since 2012, non-neonatal tetanus remains a serious public health problem. Non-neonatal tetanus is a potential fatal disease, and the mortality rate of severe cases is almost 100% in the absence of medical intervention. Even with vigorous treatment, the mortality rate is still 30~50% globally. In order to standardize the diagnosis and treatment of non-neonatal tetanus in China, this specification is hereby formulated. This standard includes etiology, epidemiology, pathogenesis, clinical manifestations, laboratory tests, diagnosis, differential diagnosis, classification, grading and treatment of non-neonatal tetanus. 破伤风分为新生儿破伤风和非新生儿破伤风。我国已于2012年消除了新生儿破伤风,但非新生儿破伤风仍是一个严重的公共卫生问题。非新生儿破伤风重症患者在无医疗干预的情况下,病死率接近100%,即使经过积极的综合治疗,全球范围病死率仍为30%~50%,是一种极为严重的潜在致命性疾病。为规范我国非新生儿破伤风诊疗行为,提高医疗质量,保障医疗安全,特制定本规范。本规范包括了非新生儿破伤风的病原学、流行病学、发病机制、临床表现及实验室检查、诊断、鉴别诊断、分级、治疗等方面内容。.

Autres résumés

Type: Publisher (chi)
破伤风分为新生儿破伤风和非新生儿破伤风。我国已于2012年消除了新生儿破伤风,但非新生儿破伤风仍是一个严重的公共卫生问题。非新生儿破伤风重症患者在无医疗干预的情况下,病死率接近100%,即使经过积极的综合治疗,全球范围病死率仍为30%~50%,是一种极为严重的潜在致命性疾病。为规范我国非新生儿破伤风诊疗行为,提高医疗质量,保障医疗安全,特制定本规范。本规范包括了非新生儿破伤风的病原学、流行病学、发病机制、临床表现及实验室检查、诊断、鉴别诊断、分级、治疗等方面内容。.

Identifiants

pubmed: 31795576
doi: 10.3760/cma.j.issn.0253-9624.2019.12.004
doi:

Types de publication

Journal Article

Langues

chi

Sous-ensembles de citation

IM

Pagination

1206-1211

Auteurs

C L Wang (CL)

Emergency Department/Trauma Center, Peking University People's Hospital, Beijing 100044, China.

S Liu (S)

Department of Emergency, Peking University First Hospital, Beijing 100034, China.

Q J Chen (QJ)

Emergency Department, Beijing Hepingli Hospital, Beijing 100013, China.

Z J Shao (ZJ)

National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

J F Wu (JF)

Surgical Department, Shijiazhuang Fifth Hospital, Shijiazhuang 050021, China.

Z Fan (Z)

Emergency Department, Peking University Shenzhen Hospital, Shenzhen 518036, China.

P G Wang (PG)

Emergency Department, The Affiliate Hospital of Qingdao University, Qingdao 266003, China.

Z G Zhu (ZG)

Wuhan Center for Disease Control and Prevention, Wuhan 430015, China.

P Lan (P)

Department of Emergency, Lishui Hospital, Zhejiang University School of Medicine, Lishui 323000, China.

J G Li (JG)

Emergency Department, Hebe general hospital, Shijiazhuang 050051, China.

Y S Zheng (YS)

Department of Critical Care Medicine, The Second Hospital of Nanjing, Nanjing 210003 China.

W B He (WB)

Provincial clinical medical college, Fujian medical university, Fuzhou 350001, China.

Z Xu (Z)

The centre of infectious diseases, the Fifth medical centre, PLA general hospital, Beijing100039, China.

W D Tang (WD)

Suzhou Road Hospital, Xinjiang Autonomous Region People's Hospital, Department of Orthopedics, Urumqi 830000, China.

J M Pang (JM)

Thyroid and breast surgery, The thirdhospital of Jinan, Jinan 250132, China.

Z H Ban (ZH)

Emergency Department, Guangxi International Zhuang Medicine Hospital, Nanning 530200, China.

S Q Yang (SQ)

Emergency Department, Chongqing Emergency Medical Center/Central Hospital of Chongqing University, Chongqing 400014, China.

W T Ding (WT)

Department of General Surgery, Tianjin First Central Hospital, Tianjin 300192, China.

X F Zheng (XF)

Department of Orthopedic Surgery, First Affiliated Hospital, Dalian Medical University, Dalian 116011, China.

Q L Zhang (QL)

Department of Emergency and Critical Care Medicine, The Jiangxi chest hospital, Nanchang 330006, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH